文献速递免疫规划

调查接种季节性流感疫苗与发生麻木/感觉异常及严重头痛的关联,加拿大2012/13至2016/17年度,加拿大疫苗安全网络

Investigating the association of receipt of seasonal influenza vaccine with occurrence of anesthesia/paresthesia and severe headaches, Canada 2012/13-2016/17, the Canadian Vaccine Safety Network.
PubMed 文献 · Vaccine · 2020-03-27

研究分析加拿大国家疫苗安全网络数据,比较接种季节性流感疫苗者与上一年度接种者(对照)在接种后0-7天自我报告的严重麻木/感觉异常及严重头痛。麻木/感觉异常总体报告率为0.10%,接种组0.09% vs 对照组0.11%(aOR=0.89;95%CI=0.60,1.32);严重头痛总体报告率为1.40%,接种组1.48% vs 对照组1.26%(aOR=1.21;95%CI=1.08,1.36)。结论认为麻木/感觉异常与流感疫苗接种无关,严重头痛虽有关联但发生率与临床试验报告相似,不引起额外担忧。

要点

  • 接种组严重头痛报告率1.48% vs 对照组1.26%(aOR=1.21;95%CI=1.08,1.36)。
  • 接种组麻木/感觉异常报告率0.09% vs 对照组0.11%(aOR=0.89;95%CI=0.60,1.32)。
  • 无特定疫苗产品与严重头痛相关。

核心结论

  • 研究发现严重麻木/感觉异常与季节性流感疫苗接种无关联。
  • 严重头痛作为免疫接种后不良事件与流感疫苗接种存在关联,但其发生率与临床试验报告相似,不引起额外担忧。

研究设计与样本

  • 数据来自加拿大国家疫苗安全网络,分析2012/13至2016/17年度数据。
  • 事件为接种后0-7天自我报告,且妨碍日常活动、导致缺勤或需就医。
  • 对照为上一年度接种者,其事件在每年流感疫苗接种计划开始前收集。
  • 采用多变量逻辑回归分析关联。
  • 麻木/感觉异常分析总样本107,565人,严重头痛分析总样本97,420人。

主要发现

  • 麻木/感觉异常总报告104/107,565(0.10%);接种组63/69,129(0.09%)vs 对照组41/38,436(0.11%),aOR=0.89;95%CI=0.60,1.32。
  • 严重头痛总报告1361/97,420(1.40%);接种组907/61,463(1.48%)vs 对照组454/35,957(1.26%),aOR=1.21;95%CI=1.08,1.36。
  • 无特定疫苗产品与严重头痛相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Concern about adverse events following immunization is frequently cited by both those who receive or decline vaccines. Neurological adverse events are especially concerning. OBJECTIVES: Our aim was to detect associations between seasonal influenza vaccination and the occurrence of severe anesthesia/paresthesia or severe headaches. METHODS: Data were analyzed from the Canadian National Vaccine Safety network. Events occuring on days 0-7 were self-reported and prevented daily activity, led to school or work absenteeism, or required medical attention. Controls were the previous year's vaccinees; events in controls were collected prior to the start of the influenza vaccination program of each year (2012/13 through 2016/17). Multivariable logistic regression was used to determine the association between seasonal influenza vaccination and the occurrence of anesthesia/paresthesia or severe headaches. RESULTS: The total sample was 107,565 for investigating anesthesia/paresthesia and 97,420 for investigating severe headaches. Anesthesia/paresthesia was reported by 104/107,565 (0.10%) participants; 63/69,129 (0.09%) vaccinees and 41/38,436 (0.11%) controls (adjusted odds ratio (aOR) = 0.89; 95% CI = 0.60, 1.32). Severe headaches were reported by 1361/97,420 (1.40%) participants; 907/61,463 (1.48%) vaccinees and 454/35,957 (1.26%) controls (aOR = 1.21; 95% CI = 1.08, 1.36). No specific vaccine product was associated with severe headaches. CONCLUSIONS: Our study found no association between severe anesthesia/paresthesia and seasonal influenza vaccination. While there was an association with severe headaches as an adverse event following influenza vaccination, the rates of these events are similar to rates reported from clinical trials and are not a cause for additional concern.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ahmed MA, Naus M, Singer J, et al. Investigating the association of receipt of seasonal influenza vaccine with occurrence of anesthesia/paresthesia and severe headaches, Canada 2012/13-2016/17, the Canadian Vaccine Safety Network. Vaccine. 2020. PMID: 32229052. doi:10.1016/j.vaccine.2020.03.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。